An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT02756858 · COMPLETED
Trial details
- NCT number
- NCT02756858
- Sponsor
- Anavex Life Sciences Corp.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-11-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.